Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic

BACKGROUND: TP53 is the most commonly mutated gene in cancer and codes for the best studied tumor suppressor, p53. MDM2 is involved in the negative regulation of p53 and itself serves as an oncogene, reported to be overexpressed in several cancer tumor types. In this retrospective study, we assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Dembla, Vikas, Somaiah, Neeta, Barata, Pedro, Hess, Kenneth, Fu, Siqing, Janku, Filip, Karp, Daniel D., Naing, Aung, Piha-Paul, Sarina Anne, Subbiah, Vivek, Tsimberidou, Apostolia M., Shaw, Kenna, Meric-Bernstam, Funda, Hong, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145698/
https://www.ncbi.nlm.nih.gov/pubmed/30237864
http://dx.doi.org/10.18632/oncotarget.26075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145698/
https://www.ncbi.nlm.nih.gov/pubmed/30237864
http://dx.doi.org/10.18632/oncotarget.26075

Ejemplares similares